Sofimac
Alta Life Sciences, Kurma lead €3.5m series-A for Deepull
Axis Participaciones and Sofimac Innovation, through Pertinence Invest 2, also take part in the round
Consortium invests €10m in Snowleader
French retailer of mountain sports equipment plans to open shops in France and abroad
Consortium invests €32m in Hoppen
New and previous investors back the French provider of IT services for the medical sector
Ixo leads €5.2m round for Care Labs
French VC's investment marks the second round of funding for Care Labs
MBO Partenaires acquires Icare from Naxicap
Naxicap Partners and Sofimac Partners entered the group as minority shareholders in 2012
Sofimac et al. in €8m Ixaltis series-A
Company will use the fresh capital to develop its product pipeline and finance clinical trials
Tertium joins €3m fourth funding round for Ideol
French company has gathered a total of €10m in funding over the last five years
Sofimac holds first close for Opportunités Régions 2 fund
BPI France is a key investor in the fund
Theranexus raises €3.6m
Company will use funds to start its first clinical programme
Sofimac closes new fund on €33m
Fund launched in June 2012; counts BPI as cornerstone
CEA Investissement leads €2m round for Microphyt
CEA Investissement, Sofimac Partners and Soridec have taken part in a €2m funding round for Microphyt, a French biotech specialising in microalgae-based bioactive products.
VC-backed Crossject to list on NYSE Alternext
French medical device company Crossject, backed by a consortium of local venture capital firms, is hoping to raise up to €12.9m in its IPO on the NYSE Alternext Paris.
CDC Entreprises et al. back Biom’Up with €6.8m
CDC Entreprises, Viveris Management, OTC Asset Management and exisitng investors have backed French manufacturer of medical devices Biom’Up with €6.8m.